FDA Inspection 1014880 — Elite Laboratories Inc.
The FDA completed an inspection of Elite Laboratories Inc. on April 24, 2017 in Northvale, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 24, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Postmarket Surv. and Epidemiology
- Location
- Northvale, NJ (United States)